Tarsus Pharmaceuticals, Inc. (TARS) Earnings
|
Expand Research on TARS
| Next EPS Date | 8/6/26 | EPS Growth Rate | +54.2% |
|---|---|---|---|
| Average EPS % Beat Rate | -28.8% | Revenue Growth Rate | +62.9% |
| Average % Move 1-Wk after EPS | +4.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.22 | N/A | N/A | $167.34M | N/A | N/A | N/A | ||
| 5/6/26 | Q126 | -$0.16 | -$0.30 | +$0.14 | $162M | $153.12M | N/A |  | | Details | |
| 2/23/26 |
Q425 | -$0.20 | -$0.08 | -$0.12 | $151.67M | $143.78M | N/A | | | Details | |
| 11/4/25 | Q325 | -$0.30 | -$0.35 | +$0.05 | $118.7M | $114.22M | N/A | | | Details | |
| 8/6/25 | Q225 | -$0.48 | -$0.38 | -$0.10 | $102.7M | $95.68M | N/A | | | Details | |
| 5/1/25 |
Q125 | N/A | -$0.79 | N/A | N/A | $69.42M | N/A | N/A | N/A | ||
| 2/25/25 | Q424 | -$0.60 | -$0.77 | +$0.17 | $66.41M | $57.53M | N/A | | | Details | |
| 11/13/24 | Q324 | -$0.61 | -$0.94 | +$0.33 | $48.1M | $43.18M | N/A | | | Details |
